The pandemic exposed global gaps in access to medicines. Can a contentious approach to close them gain traction?

January 5, 2023 |
Amid Rising Covid Fears, Wait For Patent Waiver On Meds Continues
Pfizer says it will widen access to hundreds of off-patent medicines in low-income countries
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...